Stryker Corporation
SYK · Healthcare
$317.40
Φόρτωση γραφήματος…
Νέα
Τελευταίοι τίτλοι για αυτή τη μετοχή
Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference
Stryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, to enhance its shoulder product offering. The company will also participate in the 2026 Wells Fargo Healthcare Conference on September 8, 2026.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
The iShares U.S. Medical Devices ETF (IHI) is reviewed as a passively managed fund offering diversified exposure to the healthcare medical devices sector. With $3.44 billion in assets and a 0.37% expense ratio, IHI tracks the Dow Jones U.S. Select Medical Equipment Index. The fund has declined 12.46% year-to-date and carries a Zacks ETF Rank of 3 (Hold), making it a reasonable but not exceptional choice for sector exposure.
Stryker to Acquire ZuriMED to Expand Its Shoulder Care Portfolio
Stryker announced a definitive agreement to acquire ZuriMED, developer of the FiberLocker System for rotator cuff augmentation. The acquisition aims to strengthen Stryker's shoulder portfolio and expand its rotator cuff repair capabilities in sports medicine and arthroplasty. Despite the strategic move, SYK shares fell 2.1% following the announcement, though the global rotator cuff repair market is projected to grow at 7.6% CAGR through 2033.
Aging Population Drives Healthcare Growth: Stocks to Watch
The global aging population is reshaping healthcare investment opportunities, with the geriatric care services market projected to grow from $1.24 trillion in 2025 to $2.16 trillion by 2034. Healthcare companies are capitalizing on this demographic shift through innovations in diabetes care, cardiovascular treatments, robotic surgery, and digital health solutions. Key players like AbbVie, Tandem Diabetes Care, Amgen, Stryker, and Boston Scientific are advancing AI-enabled technologies and specialized treatments for age-related conditions.
Stryker to participate in the 2026 Wells Fargo Healthcare Conference
Stryker announced its participation in the 2026 Wells Fargo Healthcare Conference on September 8, 2026, with CFO Preston Wells and VP of Investor Relations Nick Mead participating in a fireside chat. The company also declared a quarterly dividend of $0.88 per share and reported second quarter 2026 operating results with net sales increasing 9.4% to $6.6 billion.